Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-03-09

Clinical Trial Update: Sildenafil in US Heart Failure Patients (SilHF-US) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on sildenafil for US heart failure patients with pulmonary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Hartford Hospital | Conditions: Heart Failure, Pulmonary Hypertension | Phase 3 | Status: UNKNOWN